Merck & Siemens join forces to accelerate AI drug discovery and development
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
IND application for EB-003 expected in early 2026
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Element5’s Agentic AI platform will be integrated with the HCHB EHR
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
The FDA is beginning rulemaking to close the “adequate provision” loophole
CRISPR-based detection enables highly specific molecular recognition
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
Subscribe To Our Newsletter & Stay Updated